Cargando…
Comparative efficacy of different renin angiotensin system blockade therapies in patients with IgA nephropathy: a Bayesian network meta-analysis of 17 RCTs
BACKGROUND: IgA nephropathy (IgAN) is still one of the most prevalent forms of primary glomerulonephritis globally. However, no guidelines have clearly indicated which kinds of renin angiotensin system blockade therapies (ACEIs or ARBs or their combination) in patients with IgAN result in a greater...
Autores principales: | Huo, Zhihao, Ye, Huizhen, Ye, Peiyi, Xiao, Guanqing, Zhang, Zhe, Kong, Yaozhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269645/ https://www.ncbi.nlm.nih.gov/pubmed/34268008 http://dx.doi.org/10.7717/peerj.11661 |
Ejemplares similares
-
Comparative proteinuria management of different angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for normotensive patients with CKD: a Bayesian network meta-analysis
por: Ye, Huizhen, et al.
Publicado: (2020) -
Supportive Management of IgA Nephropathy With Renin-Angiotensin Blockade, the AIIMS Primary IgA Nephropathy Cohort (APPROACH) Study
por: Bagchi, Soumita, et al.
Publicado: (2021) -
Single versus dual blockade of the renin-angiotensin system in patients with IgA nephropathy
por: Lennartz, David Paul, et al.
Publicado: (2020) -
Use of low-dose sulodexide in IgA nephropathy patients on renin–angiotensin system blockades
por: Yang, Byeong Yun, et al.
Publicado: (2012) -
Prominent hyperplasia of renin-producing juxtaglomerular apparatus after chronic and complete blockade of the renin-angiotensin system in adult IgA nephropathy
por: Abe, Michiaki, et al.
Publicado: (2015)